{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:20:47Z","timestamp":1780395647213,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Publishing Company","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p>Neonatal abstinence syndrome (NAS) from in utero opioid exposure has reached epidemic levels in the United States. Although nonpharmacologic therapies form the foundation of care, many neonates require pharmacotherapy. Morphine represents the most widely used first-line agent and effectively treats the symptoms of withdrawal. However, methadone or buprenorphine may facilitate earlier discharge. Although phenobarbital is traditionally used when opioids fail, clonidine may be a more appropriate adjunctive agent to minimize negative neurodevelopmental impact. Consideration of the available data allows hospitals to generate effective pharmacologic strategies to manage NAS while further research continues.<\/jats:p>","DOI":"10.1891\/0730-0832.35.5.314","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T03:04:10Z","timestamp":1473995050000},"page":"314-320","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All"],"prefix":"10.1891","volume":"35","author":[{"given":"Christopher","family":"McPherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"793","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"2019091815151568000_35.5.314.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2010.12.050"},{"key":"2019091815151568000_35.5.314.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1500439"},{"key":"2019091815151568000_35.5.314.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3951"},{"key":"2019091815151568000_35.5.314.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.01.013"},{"key":"2019091815151568000_35.5.314.5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.earlhumdev.2008.10.001","article-title":"The complexity of examining developmental outcomes of children prenatally exposed to opiates. A response to the Hunt et al. Adverse neurodevelopmental outcome of infants exposed to opiates in-utero. Early Human Development (2008,, 84, 29-35)","volume":"85","year":"2009","journal-title":"Early Hum Dev"},{"key":"2019091815151568000_35.5.314.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3212"},{"key":"2019091815151568000_35.5.314.7","doi-asserted-by":"publisher","DOI":"10.1097\/ANC.0b013e318241bd73"},{"key":"2019091815151568000_35.5.314.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02802.x"},{"key":"2019091815151568000_35.5.314.9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4036"},{"key":"2019091815151568000_35.5.314.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1141"},{"key":"2019091815151568000_35.5.314.11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1542\/peds.113.S2.641","article-title":"The neonatal intensive care unit network neurobehavioral scale procedures","volume":"113","year":"2004","journal-title":"Pediatrics"},{"key":"2019091815151568000_35.5.314.12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-0204"},{"key":"2019091815151568000_35.5.314.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2012.06.008"},{"key":"2019091815151568000_35.5.314.14","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1989.02150200057018"},{"key":"2019091815151568000_35.5.314.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.001"},{"key":"2019091815151568000_35.5.314.16","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.52.3.329"},{"key":"2019091815151568000_35.5.314.17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","article-title":"Nucleus locus ceruleus: new evidence of anatomical and physiological specificity","volume":"63","year":"1983","journal-title":"Physiol Rev"},{"key":"2019091815151568000_35.5.314.18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","year":"2001","journal-title":"Physiol Rev"},{"key":"2019091815151568000_35.5.314.19","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(96)01236-7"},{"key":"2019091815151568000_35.5.314.20","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0172-11.2011"},{"key":"2019091815151568000_35.5.314.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.04.015"},{"key":"2019091815151568000_35.5.314.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04421.x"},{"key":"2019091815151568000_35.5.314.23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2013.08.071","article-title":"Opiate exposure and withdrawal dynamically regulate mRNA expression in the serotonergic dorsal raphe nucleus","volume":"254","year":"2013","journal-title":"Neuroscience"},{"key":"2019091815151568000_35.5.314.24","doi-asserted-by":"crossref","unstructured":"Osborn DA , Jeffery HE , Cole MJ . Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev. 2010;(10):CD002059.","DOI":"10.1002\/14651858.CD002059.pub3"},{"key":"2019091815151568000_35.5.314.25","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2014.194"},{"key":"2019091815151568000_35.5.314.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.adnc.2005.06.003"},{"key":"2019091815151568000_35.5.314.27","first-page":"1214.e3","article-title":"Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study","volume":"167","year":"2015","journal-title":"J Pediatr"},{"key":"2019091815151568000_35.5.314.28","first-page":"1221.e1","article-title":"Cohort analysis of a pharmacokinetic-modeled methadone weaning optimization for neonatal abstinence syndrome","volume":"167","year":"2015","journal-title":"J Pediatr"},{"key":"2019091815151568000_35.5.314.29","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2011.114"},{"key":"2019091815151568000_35.5.314.30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.2001.00657.x"},{"key":"2019091815151568000_35.5.314.31","doi-asserted-by":"publisher","DOI":"10.1111\/apa.12603"},{"key":"2019091815151568000_35.5.314.32","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1112"},{"key":"2019091815151568000_35.5.314.33","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.181701"},{"key":"2019091815151568000_35.5.314.34","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181c8eef3"},{"key":"2019091815151568000_35.5.314.35","first-page":"935631","article-title":"Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea","volume":"2011","year":"2011","journal-title":"Int J Pediatr"},{"key":"2019091815151568000_35.5.314.36","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"2019091815151568000_35.5.314.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03170.x"},{"key":"2019091815151568000_35.5.314.38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0571"},{"key":"2019091815151568000_35.5.314.39","first-page":"39.e1","article-title":"A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome","volume":"170","year":"2016","journal-title":"J Pediatr"},{"key":"2019091815151568000_35.5.314.40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1610","article-title":"Population pharmacokinetic model of sublingual buprenorphine in neonatal abstinence syndrome","volume":"35","year":"2015","journal-title":"Pharmacotherapy"},{"key":"2019091815151568000_35.5.314.41","doi-asserted-by":"crossref","unstructured":"Mattick RP , Breen C , Kimber J , Davoli M . Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207.","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"2019091815151568000_35.5.314.42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/glia.21253","article-title":"Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of \u03bc-opioid- and nociceptin\/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy","volume":"60","year":"2012","journal-title":"Glia"},{"key":"2019091815151568000_35.5.314.43","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu190"},{"key":"2019091815151568000_35.5.314.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2009.09.001"},{"key":"2019091815151568000_35.5.314.45","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2002.123099"},{"key":"2019091815151568000_35.5.314.46","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2013.95"},{"key":"2019091815151568000_35.5.314.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)80026-1"},{"key":"2019091815151568000_35.5.314.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.08.009"},{"key":"2019091815151568000_35.5.314.49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1471-4159.2012.07954.x","article-title":"Ethanol disrupts axon outgrowth stimulated by netrin-1, GDNF, and L1 by blocking their convergent activation of Src family kinase signaling","volume":"123","year":"2012","journal-title":"J Neurochem"},{"key":"2019091815151568000_35.5.314.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002083220604"},{"key":"2019091815151568000_35.5.314.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530190032031"},{"key":"2019091815151568000_35.5.314.52","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0978"},{"key":"2019091815151568000_35.5.314.53","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM198111193052114","article-title":"Clonidine in neonatal narcotic-abstinence syndrome","volume":"305","year":"1981","journal-title":"N Engl J Med"},{"key":"2019091815151568000_35.5.314.54","doi-asserted-by":"crossref","unstructured":"Gowing L , Ali R , White JM . Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(8):CD002025.","DOI":"10.1002\/14651858.CD002025.pub4"},{"key":"2019091815151568000_35.5.314.55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2377"},{"key":"2019091815151568000_35.5.314.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2012.02722.x"},{"key":"2019091815151568000_35.5.314.57","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31819daedd"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/0730-0832.35.5.314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T16:05:47Z","timestamp":1657296347000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/0730-0832.35.5.314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":57,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,1,1]]},"published-print":{"date-parts":[[2016]]}},"alternative-id":["10.1891\/0730-0832.35.5.314"],"URL":"https:\/\/doi.org\/10.1891\/0730-0832.35.5.314","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}